Literature DB >> 35854096

A novel RARA-SNX15 fusion in PML-RARA-positive acute promyelocytic leukemia with t(11;17;15)(q13;q21.2;q24.1).

Kentaro Hirade1, Shigeru Kusumoto1, Akihiro Abe2, Hatsune Noritake3, Asahi Ito1, Masaki Ri1, Hirokazu Komatsu1, Shinsuke Iida1, Yukiya Yamamoto4.   

Abstract

Acute promyelocytic leukemia (APL) is characterized by a series of retinoic acid receptor (RAR) fusion genes that lead to the dysregulation of RAR signaling and onset of APL. PML-RARA is the most common fusion generated from t(15;17)(q24;q21). In addition, the reciprocal fusion RARA-PML is present in over 80% of t(15;17) APL cases. The bcr3 types of RARA-PML and RARA-PLZF in particular are reciprocal fusions that contribute to leukemogenesis. Here, we report a variant APL case with t(11;17;15)(q13;q21.2;q24.1). Massive parallel sequencing of patient RNA detected the novel fusion transcripts RARA-SNX15 and SNX15-LINC02255 along with the bcr3 type of PML-RARA. Genetic analysis revealed that RARA-SNX15L is an in-frame fusion due to intron retention caused by RNA mis-splicing. RARA-SNX15L consisted mainly of SNX15 domains, including the Phox-homology domain, which has a critical role in protein-protein interactions among sorting nexins and with other partners. Co-immunoprecipitation analysis revealed that RARA-SNX15L is directly associated with SNX15 and with itself. Further studies are needed to evaluate the biological significance of RARA-SNX15L in APL. In conclusion, this is the first report of APL with a complex chromosomal rearrangement involving SNX15.
© 2022. Japanese Society of Hematology.

Entities:  

Keywords:  Acute promyelocytic leukemia; Chromosomal translocation; LINC02255; Reciprocal fusion; SNX15

Year:  2022        PMID: 35854096     DOI: 10.1007/s12185-022-03421-w

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.319


  1 in total

1.  Atypical mRNA fusions in PML-RARA positive, RARA-PML negative acute promyelocytic leukemia.

Authors:  Christoph Walz; David Grimwade; Susanne Saussele; Eva Lengfelder; Claudia Haferlach; Susanne Schnittger; Marina Lafage-Pochitaloff; Andreas Hochhaus; Nicholas C P Cross; Andreas Reiter
Journal:  Genes Chromosomes Cancer       Date:  2010-05       Impact factor: 5.006

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.